Le Registre du Cancer de la Somme : publications et rapports

Seigneurin A., Delafosse P., Trétarre B., Woronoff AS., Velten M., Grosclaude P., Guizard AV., Lapôtre-Ledoux B., Bara S12, Molinié F., Colonna M. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries. BMC Cancer. 2018 Nov 12;18(1):1091.

Colonna M, Boussari O, Cowppli-Bony A, Delafosse P, Romain G, Grosclaude P, Jooste V; French Network of Cancer Registries (FRANCIM). Time trends and short term projections of cancer prevalence in France. Cancer Epidemiol. 2018 (August 17); 56:97-105.

Desandes E, Brugières L, Molinié F, Defossez G, Delafosse P, Jehannin-Ligier K, Velten M, Trétarre B, Amadéo B, Marrer E, Woronoff AS, Ganry O, Monnereau A, d’Almeida T, Troussard X, Daubisse-Marliac L, Bara S, Guizard AV, Baldi I0, Launoy G, Clavel J, Lacour B. “Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care.” Pediatr Blood Cancer. 2018 (May 17).

Bello Roufai D, Caillet P, Lapôtre-Ledoux B, Trecherel E, Bauchet L, Chauffert B, and Ganry O. “Incidence and Survival Rates for Adult Malignant Neuro-Epithelial Brain Tumors in the Somme County (France): A Retrospective, Population-Based Study from 2003 to 2013.” Journal of Cancer Policy 15 (March 2018): 5–9.

Jégu J, Moitry M, Bara S, Trétarre B, Guizard AV, Woronoff AS, Daubisse-Marliac L, et al. “Methodological Issues of Assessing the Risk of a Second Cancer Occurring in the Same Site as a First Cancer Using Registry Data.” Cancer Epidemiology 51 (December 2017): 41–43.

ICARE study group, Barul C, Fayossé A, Carton M, Pilorget C, Woronoff AS, Stücker I, and Luce D. “Occupational Exposure to Chlorinated Solvents and Risk of Head and Neck Cancer in Men: A Population-Based Case-Control Study in France.” Environmental Health 16, no. 1 (December 2017).

Cowppli-Bony A, Uhry Z, Remontet L, Voirin N, Guizard AV, Trétarre B, Bouvier AM, et al. “Survival of Solid Cancer Patients in France, 1989–2013: A Population-Based Study.” European Journal of Cancer Prevention 26, no. 6 (November 2017): 461–68.

Bousquet P-J., Caillet P, Coeuret-Pellicer M, Goulard H, Kudjawu Y-C, Le Bihan C, Lecuyer A-I and Séguret F. “Recherche d’algorithmes d’identification des cancers dans les bases médico-administratives : premiers résultats des travaux du groupe REDSIAM Tumeurs sur les cancers du sein, du côlon-rectum et du poumon.” Revue d’Épidémiologie et de Santé Publique 65 (October 2017): S236–42.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, et al. “Quality Analysis of Population-Based Information on Cancer Stage at Diagnosis across Europe, with Presentation of Stage-Specific Cancer Survival Estimates: A EUROCARE-5 Study.” European Journal of Cancer 84 (October 2017): 335–53.

Soumaya BK, Neri M, Guida F, Matrat M, Cenée S, Sanchez M, Menvielle G, Molinié F, Luce D, and Stücker I. “Occupational Exposure to Endotoxins and Lung Cancer Risk: Results of the ICARE Study.” Occupational and Environmental Medicine 74, no. 9 (September 2017): 667–79.

Bryere J, Menvielle G, Dejardin O, Launay L, Molinie F, Stucker I, Luce D, and Launoy G. “Neighborhood Deprivation and Risk of Head and Neck Cancer: A Multilevel Analysis from France.” Oral Oncology 71 (August 2017): 144–49.

Guizard AV , Dejardin O, Launay L, Bara S, Lapôtre-Ledoux B, Babin E, Launoy G, and Ligier K. “Diagnosis and Management of Head and Neck Cancers in a High-Incidence Area in France: A Population-Based Study.” Medicine 96, no. 26 (June 2017): e7285.

Jéhannin-Ligier K, Belot A, Guizard AV, Bossard N, Launoy G, Uhry Z, and the FRANCIM network. “Incidence Trends for Potentially Human Papillomavirus-Related and -Unrelated Head and Neck Cancers in France Using Population-Based Cancer Registries Data: 1980-2012: Incidence Trends for Potentially Human Papillomavirus-Related and -Unrelated Head and Neck Cancers in France.” International Journal of Cancer 140, no. 9 (May 1, 2017): 2032–39.

Moitry M, Velten M, Trétarre B, Bara S, Daubisse-Marliac L, Lapôtre-Ledoux B, Troussard X, et al. “Development of a Model to Predict the 10-Year Cumulative Risk of Second Primary Cancer among Cancer Survivors.” Cancer Epidemiology 47 (April 2017): 35–41.

Jéhannin-Ligier K, Dejardin O, Lapôtre-Ledoux B, Bara S, Coureau G, Grosclaude P, Marrer E, et al. “Oral Cancer Characteristics in France: Descriptive Epidemiology for Early Detection.” Journal of Stomatology Oral and Maxillofacial Surgery 118, no. 2 (April 2017): 84–89.

Guizard AV, Uhry Z, De Raucourt D, Mazzoleni G, Sánchez MJ, and Ligier K. “Trends in Net Survival from Head and Neck Cancer in Six European Latin Countries: Results from the SUDCAN Population-Based Study.” European Journal of Cancer Prevention 26 (January 2017): S16–23.

Carton M, Barul C, Menvielle G, Cyr D, Sanchez M, Pilorget C, Trétarre B, Stücker I, and Luce D. “Occupational Exposure to Solvents and Risk of Head and Neck Cancer in Women: A Population-Based Case–control Study in France.” BMJ Open 7, no. 1 (January 2017): e012833.

Muller J, Grosclaude P, Lapôtre-Ledoux B, Woronoff A-S, Guizard A-V, Bara S, et al. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.
BJU Int. 2016 Jul;118(1):53–9.

Mattei F, Liverani S, Guida F, Matrat M, Cenée S, Azizi L, et al.
Multidimensional analysis of the effect of occupational exposure to organic solvents on lung cancer risk: the ICARE study.
Occup Environ Med. 2016 Jun;73(6):368–77.

Guizard A-V, Dejardin O, Launay L, Bara S, Lapôtre-Ledoux B, Babin E, et al.
What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.
Eur Arch Otorhinolaryngol. 2016 Apr 27;

Matrat M, Guida F, Mattei F, Cénée S, Cyr D, Févotte J, et al.
Welding, a risk factor of lung cancer: the ICARE study.
Occup Environ Med. 2016 Apr;73(4):254–61.

Menvielle G, Fayossé A, Radoï L, Guida F, Sanchez M, Carton M, et al.
The joint effect of asbestos exposure, tobacco smoking and alcohol drinking on laryngeal cancer risk: evidence from the French population-based case-control study, ICARE.
Occup Environ Med. 2016 Jan;73(1):28–33.

Trétarre B, Molinié F, Woronoff A-S, Bossard N, Bessaoud F, Marrer E, et al.
Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
Gynecol Oncol. 2015 Nov;139(2):324–9.

Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, et al.
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
Lancet Haematol. 2015 Nov;2(11):e481-491.

Jégu J, Belot A, Borel C, Daubisse-Marliac L, Trétarre B, Ganry O, et al.
Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.
Oral Oncol. 2015 May;51(5):457–63.

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, et al.
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Lancet. 2015 Mar 14;385(9972):977–1010.

Rossi C, Jégu J, Mounier M, Dandoit M, Colonna M, Daubisse-Marliac L, et al.
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.
Leuk Lymphoma. 2015;56(10):2876–82.

Radoï L, Menvielle G, Cyr D, Lapôtre-Ledoux B, Stücker I, Luce D, et al.
Population attribuable risks of oral cavity cancer to behavioral and medical risk factors in France: results of a large population-based case-control study, the ICARE study.
BMC Cancer. 2015;15:827.